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Abstract
Functional T-cell responses are initiated by physical interactions between T-cells and antigen-presenting cells (APCs),
including dendritic cells (DCs) and B-cells. T-cells are activated more effectively by DCs than by B-cells, but little is known
about the key molecular mechanisms that underpin the particular potency of DC in triggering T-cell responses. To better
understand the influence of physical intercellular interactions on APC efficacy in activating T-cells, we used single cell force
spectroscopy to characterize and compare the mechanical forces of interactions between DC:T-cells and B:T-cells. Following
antigen stimulation, intercellular interactions of DC:T-cell conjugates were stronger than B:T-cell interactions. DCs induced
higher levels of T-cell calcium mobilization and production of IL-2 and IFNc than were elicited by B-cells, thus suggesting
that tight intercellular contacts are important in providing mechanically stable environment to initiate T-cell activation.
Blocking antibodies targeting surface co-stimulatory molecules CD80 or CD86 weakened intercellular interactions and
dampen T-cell activation, highlighting the amplificatory roles of CD80/86 in regulating APC:T-cell interactions and T-cell
functional activation. The variable strength of mechanical forces between DC:T-cells and B:T-cell interactions were not solely
dependent on differential APC expression of CD80/86, since DCs were superior to B-cells in promoting strong interactions
with T-cells even when CD80 and CD86 were inhibited. These data provide mechanical insights into the effects of co-
stimulatory molecules in regulating APC:T-cell interactions.
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Introduction
Adaptive immune responses are initiated by specific interactions
between T-cells and antigen-presenting cells (APCs). T-cell
activation involves the formation of specialized structures at areas
of APC:T-cell intercellular contact, which have been termed
immunological synapses (IS) [1,2,3,4,5]. The shape and structure
of IS on the T-cell surface are influenced by encountering with
different types of APC, including dendritic cells (DCs) and B-cells
[6]. While resting B-cells induce the formation of a singular,
mature IS, multifocal IS have been observed between T-cells and
DCs [4,7,8]. In addition to inducing distinct IS conformations,
DCs and B-cells also differ in their expression of cell-surface
adhesion molecules [9,10,11,12], as well as their surface
morphology and cytoskeletal dynamics [10,13]. While these
distinct characteristics have been convincingly shown to impact
on the ability of APC subsets to regulate T-cell activation
[4,7,8,9,10,11,12,13,14,15,16,17], studies on the role of biophys-
ical interactions between T-cells and APCs remain limited.
Previous reports have demonstrated that the duration of cell:cell
interactions is inversely correlated with APC potency in activating
T-cells [10,13,15,16,18]. Indeed DC:T-cell interactions are both
more dynamic and more potent in inducing T-cell activation when
compared with the long contact duration that occurs between T-
cells and resting B-cells. These studies have provided novel insights
into the temporal dynamics of biophysical interactions in IS, but so
far there has been no systematic analysis of the mechanical
strength of interactions between T-cells and different type of
APCs, and the consequences of these interactions for T-cell
activation.
We have previously shown that immune synapse formation
determines the interaction forces between T-cells and B-cells [19].
Moreover, we have shown that the mechanical interactions
between T-cells and DCs correlate with T-cell functional
responsiveness [20]. In the current report, we have used antigen-
specific T-cells that specifically recognize ovalbumin-derived
peptide [21,22] combined with single cell force spectroscopy
(SCFS) [19,20,23,24] to compare and characterize the mechanical
force of T-cell interactions with DCs and B-cells. Our data
indicate that upon stimulation with antigenic peptides, DC:T-cell
interactions were far stronger than B:T-cell interactions. Stronger
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DC:T-cell interactions were associated with more efficient T-cell
activation, as assessed by elevated calcium mobilization and higher
secretion levels of cytokines IL-2 and IFN-c. Dampened T-cell
activation was associated with the weakened APC:T-cell interac-
tions when blocked by using antibodies targeting co-stimulus
molecules CD80 and CD86, suggesting that CD80 and CD86 are
important in strengthening intercellular interactions and amplify-
ing T-cell functional activation. However, DC:T-cell interactions
still remained stronger than B:T-cell interactions despite inhibition
of co-stimulatory molecules CD80 and CD86, indicating that the
variable strength of mechanical forces between DC:T-cells and
B:T-cell interactions were not solely contributed by the differential
APC expression of co-stimulatory molecules CD80 and CD86.
Taken together, these data provided mechanical insights into the




OT-I.Rag1-/- mice [22,25] were provided by Taconic from the
National Institute of Allergy and Infectious Diseases Exchange
Program (# 004175; Bethesda, MD) and maintained at the SPF
animal facility of the Biological Resource Centre (BRC) of Biopolis
in Singapore.
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Institutional Animal Care
and Use Committee (IACUC) of the Biological Resource Centre
(BRC) of Biopolis in Singapore. The BRC IACUC protocol was
approved by the National Advisory Committee for Laboratory
Animal Research in Singapore (Permit Number: 110626).
Cells, Peptides and antibodies
The splenic D1 dendritic cell line [26], and the B-cell
hybridoma LB27.4 [27], which expresses MHC class-I H-2kb
and is able to present Ova-peptide SIINFEKL were used in these
analyses. Splenic CD8+ T-cells were purified from OT-I mice by
negative selection using CD8a+ T-cell isolation kit II (Miltenyi
Biotec) according to the manufacturer’s protocol. Freshly isolated
OT-I T-cells were maintained at 37uC in endotoxin free Iscove’s
Modified Dulbecco’s Medium (IMDM, EUROCLONE) contain-
ing 10% fetal bovine serum (100 IU/ml Penicillin, 100 mg/ml
Streptomycin, 2 mM Glutamine, and 50 mM b-mercaptoethanol
(all from GIBCO) before use in atomic force microscopy
experiments. Ova Peptides (SIINFEKL) were purchased from
Anaspec Corporation.
Flow Cytometry
DCs or freshly isolated OT-I T-cells were stained with
antibodies against cell surface molecules and were measured by
BD FACSCalibur flow-cytometer. Antibodies: biotinylated anti-
mouse CD43 (S7), FITC-conjugated murine (BALBC/c) anti-
mouse H-2Kb (AF6-88.5), hamster anti-mouse CD11c-APC
(HL3), rat anti-mouse CD19-PE (1D3), hamster anti-mouse
CD54-FITC (3E2), hamster anti-mouse CD80-PE (16-10A1), rat
anti-mouse CD86-PE (GL1) and anti-mouse Ova-H-2Kb (25-
DC.16, eBioscience). Isotype controls: FITC mouse IgG2a k
(G155-178), APC hamster IgG1, l1 (G235-2356), PE rat IgG2a, k
(R35-95), FITC hamster IgG1 k (A19-3) and PE hamster IgG2, k
(B81-3) (all from BD PharMingen).
Functionalization of Atomic Force Microscopy (AFM)
Cantilevers
Functionalization of AFM cantilever was performed as previ-
ously described [19,20]. Briefly, soft tip-less silicon nitride tips (NP-
O10, Veeco, Santa Barbara, CA) with a nominal spring constant
of 0.06 N/m were coated with biotinylated BSA (0.5 mg/ml in
0.1 M NaHCO3, Sigma) over night at 37uC. After washing three
times with PBS, the tips were incubated in 0.5 mg/ml streptavidin
(Sigma-Aldrich) for 1 h. Cantilevers were washed again and
incubated with 0.5 mg/ml of biotinylated anti-CD43 antibody
(BD PharMingen) for 1 h. Prior to each experiment, the spring
constant of the cantilever was determined using the built-in
thermal tune module of the AFM.
Single Cell Force Spectroscopy
The basic principles of single cell force spectroscopy using AFM
have been described elsewhere [19,20,23,24]. AFM measurements
were performed with a MultiModeTM PicoforceTM AFM (Veeco)
coupled to a microscope using fluid cell-in-cell culture medium at
37uC on a heated plate. One day before the experiment, APCs
were seeded onto round cover slips and incubated overnight to
allow firm adhesion. Non-adherent cells were washed away and
not used for Single Cell force Spectroscopy. APCs were pulsed or
not with peptides 4 h before the AFM experiment. Peptide-pulsed
APCs were maintained in the continuous presence of the same
concentration of Ova peptides in cell culture medium without
washing. Freshly isolated T-cells were attached to the anti-CD43
functionalized cantilever. Force-distance curves were obtained by
positioning the cantilever with the attached OT-I T-cell onto the
adherent APC on the cover slip and applying contact force of
1 nN with predefined contact duration. The retraction speed was
set to 1 mm/s for all measurements in all conditions for
comparative purposes. For long contact durations (3 minutes) a
new T-cell was attached to the cantilever for each AFM
measurement. At least 10 pairs of APC:T-cell interactions were
probed for each experimental point. All data were analyzed with
MATLAB (The MathWorks, Natick, MA) to quantify the
interaction force of individual APC:T-cell conjugates.
ELISA cytokine assay
DCs or B-cells were pre-pulsed for 4 h with different Ova
peptide concentrations and were then co-cultured with OT-I T-
cells in 96-well plates (56104 DC and 56104 T-cells per well)
without washing. IL-2 and IFN-c secretion were measured by
ELISA after 24 h of co-culture.
Calcium mobilization
Freshly isolated OT-I T-cells were incubated with 1 mM Fluo-4-
AM and 10 mM Fura-Red-AM (Invitrogen) at 37uC for 1 h in cell
culture medium. After washing twice with medium, the T-cells
were allowed to bind to DCs or B-cells grown on glass-bottom
dishes (MatTek). Calcium responses in individual T-cells were
measured using an inverted microscope (Olympus IX81) with a
60X objective. The T-cells were illuminated at 488 nm and the
fluorescent emission of Fluo-4-AM and Fura-Red-AM was
captured every 5 s by time-lapse confocal imaging (Olympus
FV1000) and then analysed with Imaris software (Bitplane).
Integrated Fluo-4/Fura-Red ratio was calculated from fluorescent
images as a measurement for intracellular calcium concentration.
Blocking of CD80 and CD86
For blocking experiments, APCs were incubated with 10 mg/ml
antibodies against CD80 (16-10A1) and/or CD86 (GL1) for
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30 min at 37uC prior to AFM experiments, or for 24 h prior to the
ELISA cytokine assays. Hamster IgG2 k (B81-3) and rat IgG2a k
(R35-95) were used as isotype controls in the blocking experi-
ments. All AFM and ELISA cytokine measurements were
performed in the continuous presence of the same concentration
of the blocking antibodies in cell culture medium.
Results
Dendritic Cells and B-cells Express Comparable Levels of
MHC Class I
To directly compare DC:T-cell and B:T-cell interactions, we
used the well characterized D1 cells derived from splenic DCs
[26], alongside B-cell hybridoma LB27.4 [27] which expresses
MHC class-I H-2Kb and can present antigenic ovalbumin peptide
Ova 257–264 (SIINFEKL) to OT-I T-cells [21]. FACS analysis
confirmed that the purity of DCs (CD11c+, H-2kb+) and B-cells
(CD19+, H-2Kb +) was .98%, allowing us to investigate DC:T-
cell and B:T-cell interactions at the single cell level. Expression of
surface markers CD54 (ICAM-1), CD80 (B7-1) and CD86 (B7-2)
are shown in Fig. 1. B-cells expressed the same surface level of
MHC-I and CD86 as DC, but displayed slightly lower levels of
ICAM-1 and CD80. In addition, Ova peptide could be loaded
successfully onto both DCs and B-cells, as determined by staining
with an antibody against Ova-bound H-2Kb (H-2Kb/OVA,
Fig. 1).
T-cell Activation is Promoted More Efficiently by DCs
than by B-cells
To evaluate how T-cell activation was influenced by different
antigen-loaded APC subsets, we measured cytokine secretion upon
T-cell stimulation by DCs or B-cells pre-pulsed with antigenic Ova
peptides at different concentrations (10 pg-10 mg/ml). Fig. 2 shows
that antigen-pulsed DCs activate OT-I cells more potently than B-
cells presenting comparable amounts of peptide, as measured by
release of IL-2 and IFN-c.
To measure T-cell activation at earlier time points we also
assayed the calcium response of OT-I T-cells after stimulation
with peptide-pulsed DCs or B-cells. Fig. 3A shows representative
calcium responses of T-cells bound to DC or B-cells pre-incubated
with Ova peptide (10 ng/ml). In the absence of peptide, the
calcium signal in DC:T-cell and B:T-cell conjugates remained low,
as indicated by a low Fluo-4/Fura ratio. In contrast, intracellular
calcium was rapidly mobilized in the presence of Ova peptide, and
calcium levels progressively increased during the 3 min observa-
tion period (Fig. 3B). To directly compare the calcium responses of
T-cells bound to the different types of APC, we integrated the
Fluo-4/Fura ratio [20,28] of cell:cell conjugates for a contact
duration of 3 min (Fig. 3B). The average calcium responses of T-
cells after exposure to APCs pre-pulsed with Ova peptides are
shown in Fig. 3C.
The magnitude of the calcium responses in the APC:T-cell
conjugates varied according to the concentration of peptides
pulsed onto the APCs, but at a constant peptide concentration,
DCs were superior to B-cells at inducing calcium responses in T-
cells. In addition, the threshold peptide concentration required by
DCs to trigger optimal calcium responses in T-cells (10 ng/ml)
was 10-fold less than that required by B-cells (100 ng/ml; Fig. 3C).
Increasing peptide pulse concentrations beyond these threshold
levels resulted in impaired calcium responses in the stimulated T-
cells (Fig. 3C).
Differential Strength of Mechanical Forces between
APC:T-cell Conjugates
We used single cell force spectroscopy (SCFS) to investigate the
mechanical force of DC:T-cell and B:T-cell interactions (Fig. 4A).
To quantify the strength of these mechanical interactions, the
maximal interaction force (F) [19,20,23,29] was determined for
individual cell:cell conjugates (Fig. 4B). The average interaction
force was used to compare interactions between DC:T-cell and
B:T-cell in response to antigen stimulation.
The interaction forces of DC:T-cell (black bar) in the absence
and presence of Ova peptide (10 ng/ml) are shown in Fig. 4C. We
observed that the DC:T-cell interaction force in the presence of
Ova peptide after ,1–3s contact duration (average interaction
force 0.3260.02 nN) was increased after 3 min contact duration
(1.5760.25 nN). In the absence of Ova peptide the interaction
force was weak (,0.4 nN), highlighting the requirement for Ova
peptide in establishing strong interaction forces between Ova-
specific T-cells and DCs. B:T-cell interactions were also strength-
Figure 1. B-cells and DCs exhibit a similar phenotype. B-cells (Red) and DCs (Black) were stained with antibodies against H-2Kb (MHC class I), H-
2Kb/Ova (pMHC), CD11c, CD19, CD54 (ICAM-1), CD80 (B7-1) and CD86 (B7-2). Filled histograms: isotype controls; Unfilled histograms: staining with
antibody. Data are representative of three independent experiments.
doi:10.1371/journal.pone.0045185.g001
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ened after antigen stimulation, exhibiting an interaction force of
0.0760.01 nN after 1–3s, and 0.2860.02 nN after a contact
duration of 3 min (red bar, Fig. 4C). However, the B:T-cell
binding forces (,0.4 nN) were significantly lower than was
observed for DC:T-cell interactions (Fig. 4C), confirming that
DCs are superior to B-cells in establishing tight interactions with
antigen-specific T-cells.
CD80 and CD86 Contribute to Strong DC:T-cell
Interaction Forces
We have previously shown that both TCR-pMHC and LFA-1/
ICAM-1 are important adhesion molecules in promoting strong
DC:T-cell interactions [20]. We therefore performed blocking
experiments using antibodies targeting CD80 (B7-1) and CD86
(B7-2) molecules, which were expressed both on the surface of DCs
and B-cells (Fig. 1). As shown in Fig. 5A, antibodies to CD80 and
CD86 reduced the interaction forces of DC:T-cell conjugates to
0.9660.12 nN and 0.6760.16 nN respectively. When CD80 and
CD86 were blocked simultaneously, the average interaction force
of DC:T-cell conjugates was decreased further (0.3860.04 nN).
However, B:T-cell interactions remained weaker than DC:T-cell
interactions under all conditions, with interaction forces ,0.4 nN
in all cases (Fig. 5A).
To investigate whether the force reduction upon inhibition of
CD80 and CD86 resulted in impaired T-cell activation, we
measured IL-2 and IFN-c release after antibody blockade of co-
stimulation. Consistent with the force measurement data, both IL-
2 and IFN-c secretion were reduced in CD80 or CD86 blocking
conditions. The reduction in cytokine release was most significant
when both CD80 and CD86 co-stimulation were inhibited
simultaneously (Fig. 5B, 5C), confirming the key role played by
co-stimulatory molecules in functional T-cell activation.
Discussion
We used single cell force spectroscopy to characterize and
compare the mechanical force of DC:T-cell and B:T-cell
interactions following antigen recognition. Our data reveal that
DCs are superior to B-cells in establishing strong interactions with
T-cells upon antigen stimulation. The differential strength of APC
interactions with T-cells are complex, and cannot be explained
solely by differences in MHC class I expression, or by differences
in APC antigen loading, since both DCs and B-cells displayed
similar levels of H-2Kb/Ova complexes at the cell surface.
Cellular binding forces depend on the recognition of co-
stimulatory molecules including CD80 and CD86. Accordingly,
treatment with CD80/86 blocking antibodies reduced the
interaction force of cell:cell conjugates. Both CD80 and CD86
can bind to the T-cell stimulatory receptor CD28
[30,31,32,33,34], and to the inhibitory receptor CTLA4
[35,36,37]. CD86 appeared to strengthen DC:T-cell interactions
more markedly than CD80, since higher force reduction was
observed after blocking CD86 alone than was achieved by
disrupting CD80 alone. The ability of CD86 to induce stronger
DC:T-cell interactions is consistent with the crucial role played by
this molecule in initiating immune responses [38,39]. However,
DC:T-cell interaction forces could not be completely abrogated by
single antibody blockade of CD80 or CD86, which could perhaps
be due to the functional redundancy of these co-stimulatory
markers [40,41]. Differential surface expression of CD80/86
Figure 2. Cytokine secretion by DC:T-cell and B:T-cell co-cultures. (A) and (B): secretion of IL-2 (left) and IFN-c (right) after 1 day co-culture of
CD8+ OT-I T-cells with DCs or B-cells pre-pulsed or not with Ova peptide (10 pg–10 mg/ml). *p,0.01; **p,0.001, unpaired t-test. Bars indicate mean
6 s.e.m. Data are representative of three independent experiments.
doi:10.1371/journal.pone.0045185.g002
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between DCs and B-cells cannot explain the differences in binding
strength that we observed between DC:T-cell and B:T-cell
interactions, since DCs were consistently superior to B-cells in
establishing strong interactions with T-cells, even when subject to
complete blockade of CD80 and CD86 molecules. However, there
may be intrinsic functional differences in the signaling triggered by
these co-stimulatory molecules between different APC popula-
tions, which could perhaps account for the functional differences
observed between DC:T-cell and B:T-cell interactions [14].
T-cell activation is initiated by the immunological synapse (IS)
formed at the intercellular contacts between APCs and antigen-
specific T-cells. The IS has been demonstrated to be a dynamic
complex that consists not only the TCRs, but also sets of co-
stimulatory receptors and ligands [42,43,44,45,46,47,48,49,50,51].
CD28, the most powerful T-cell co-stimulatory receptors for
Figure 3. Calcium response of T-cells bound to APCs. (A) Representative differential interference contrast (DIC) images of the DC:T-cell or B:T-
cell conjugates overlaid with the Fluo-4 (green) and Fura-red (red) fluorescent signals (loaded in T-cells only) at the indicated time points. DCs or B-
cells were pre-pulsed or not with Ova peptides (10 ng/ml) for 4 h prior to co-culture with T-cells. (B) Time course of intracellular calcium
concentrations in the responding T-cells, as measured by Fluo-4/Fura-red ratio. Each plot represents data from a pair of cell:cell conjugates. (C)
Average calcium response of T-cells bound to DC (black) or B-cell (red) pre-pulsed with Ova peptides at different concentrations (0.1 ng–1 mg/ml). To
quantify early calcium response in T-cells, Fluo-4/Fura-red ratios were measured every 5s in responding T-cells and were then integrated for 3 min
from the time of the initial calcium increase (grey line, Fig 4B). For each condition, the average calcium response was measured by pooling data of
APC:T-cell conjugates (n.15 pairs of cells) from .3 independent experiments. Bars indicate mean 6 s.e.m. *p,0.01, unpaired t-test.
doi:10.1371/journal.pone.0045185.g003
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CD80 or CD86, has been shown to localize coordinately with
TCRs to form microclusters that are able to recruit protein kinase
C h (PKCh) to initiate T-cell activation [45,52,53]. In addition to
the functional roles of modulating T-cell responses, CD28 may
also modify morphological features of the IS [54,55,56]. Previ-
ously, we have shown that IS formation determines the interaction
forces between T cells and APCs [19]. Here, APC:T-cell
interactions were weakened by CD80 and/or CD86 blocking,
which could directly inhibit CD28 signaling that stabilizes IS by
promoting enlarged contact area between APC:T-cell conjugation
[54,57]. Alternatively, inhibition of CD28 signaling may interfere
with the regulation of cytoskeletal signaling through the small
guanosine triphosphate hydrolase (GTPase), Rac1 and/or cell
division cycle 42 (Cdc42) [55,56], or the accumulation of lipid raft
or raft-localizing molecules [44,46,58,59,60] at IS. This could
explain why force reduction was observed followed by the
inhibition of CD28 signalling since cytoskeleton dynamics and
Figure 4. Differential Strength of Mechanical Forces between APC:T-cell Conjugates. (A) Schematic illustration of AFM experiments. A T-
cell-mounted AFM cantilever was placed above a DC or B-cell that was firmly attached to a glass cover slip. The T-cell was then brought into contact
with the target cell. Interaction forces were measured by the deflection of the cantilever after a pre-defined contact time. (B) Corresponding force-
distance curve of DC:T-cell (black) or B:T-cell (red) interactions. F represents maximal interaction force (double arrow). (C) Interaction forces of DC:T-
cell (black) or B:T-cell conjugates (red) in the absence (-Ova) or presence of Ova peptide (+Ova) for contact time of ,1–3 sec and 3 min. *p,0.01,
unpaired t-test. Bars indicate mean 6 s.e.m (n.10 pairs of cells). For each condition, OT-I T-cells were isolated from .3 independent experiments.
doi:10.1371/journal.pone.0045185.g004
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membrane lipid rafts are important in promoting strong interac-
tions between T-cells and APCs [61].
Our data provide novel insights into the amplificatory roles of
co-stimulus molecules CD80 and CD86 in strengthening APC:T-
cell interactions. As compared to B:T-cell interactions, stronger
DC:T-cell interactions are likely to provide a mechanically stable
environment that induces potent functional T-cell activation.
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